NASDAQ:INAB • US45674E2081
We assign a fundamental rating of 1 out of 10 to INAB. INAB was compared to 521 industry peers in the Biotechnology industry. INAB may be in some trouble as it scores bad on both profitability and health. INAB is valued expensive and it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -123.2% | ||
| ROE | -156.63% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.99 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.91 | ||
| Quick Ratio | 6.91 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:INAB (2/27/2026, 4:10:04 PM)
1.74
+0.03 (+1.75%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.29 | ||
| P/tB | 1.29 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -123.2% | ||
| ROE | -156.63% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 2.56% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.91 | ||
| Quick Ratio | 6.91 | ||
| Altman-Z | -11.99 |
ChartMill assigns a fundamental rating of 1 / 10 to INAB.
ChartMill assigns a valuation rating of 1 / 10 to IN8BIO INC (INAB). This can be considered as Overvalued.
IN8BIO INC (INAB) has a profitability rating of 0 / 10.
The Earnings per Share (EPS) of IN8BIO INC (INAB) is expected to grow by 73.62% in the next year.